Sept. 9, 2020
TOWN HALL MEETING: THE IMPACT OF COVID-19 ON THE PROSTATE CANCER RACIAL DISPARITY?
This session includes African American prostate cancer patients, wives/caregivers, doctors from around the country discussing their experiences and perspectives on managing prostate cancer during the COVID-19 pandemic. Understanding how COVID-19 might have a long-term impact on the prostate cancer racial disparity will be discussed.
Sept. 16, 2020
CLINICAL TRIALS, IMPORTANT STUDIES AND AFRICAN AMERICAN PATIENTS
New classes of therapies now being studied in clinical trials to take advantage of patients’ genetic information, the body’s immune system, and more, are shaping the next generation of prostate cancer treatments. This session will review some of these therapies and the implications for African American patients. Some findings from the landmark RESPOND study of African American patients will also be presented.
Sept. 23, 2020
UNDERSTANDING TREATMENT PATHWAYS FOR PROSTATE CANCER AND EMPOWERING PATIENTS
With a growing number of new treatments approved by the FDA, treatment pathways for prostate cancer patients are expanding and becoming more complex. This makes it extremely difficult for patients to make informed shared-decisions with their doctors treatment options. This session will review current treatment pathways and introduce a new tool for patients to use that will allow them to interface with their doctors in making decisions about their treatment options.
Sept. 30, 2020
THE IMPORTANCE OF COMMUNITY OUTREACH AND ENGAGEMENT ON ELIMINATING THE PROSTATE CANCER RACIAL DISPARITY
This session examines the role and importance of community outreach and engagement towards eliminating the prostate cancer racial disparity. Initiatives that have proven effective will be examined and discussed to understand the key elements that made them successful with the objective of identifying models that can be expanded and replicated.